Q1 2023 Swedish Orphan Biovitrum AB (publ) Earnings Call Transcript
()-&
Thank you so much, and hello, everybody this is Guido Oelkers, CEO of Sobi. Welcome to our first quarter 2023 conference call for investors and analysts. As usual, the presentation was posted to sobi.com earlier today. And basically, as per usual as well on Slide 2, please take note of the safe harbor statement. And unless stated otherwise, we will be making comments that relate mostly to first quarter performance in 2023 at constant exchange rate, and in million Swedish Krona.
Let's turn to Slide #3. This is, let's say, and this is the agenda where we plan to cover all the key aspects of the report today. We are going to share with you presentations on Q1, followed by Q&A until around 3:00 p.m. Swedish time. And please keep your questions short and we will try to keep our answers also pretty much to the point. (Operator Instructions) In speaking order, I'm joined by Henrik, our CFO; and Tony Hoos, our new Head of R&D, MA; and Armin, our Senior Scientific American offices
| Access to All Earning Calls and Stock Analysis | |
| 30-Year Financial on one screen | |
| All-in-one Stock Screener with unlimited filters | |
| Customizable Stock Dashboard | |
| Real Time Insider Trading Transactions | |
| 8,000+ Institutional investors’ 13F holdings | |
| Powerful Excel Add-in and Google sheets Add-on | |
| All data downloadable | |
| Quick customer support | |
| And much more... |
Trustpilot
We'd love to learn more about your experiences on GuruFocus.com and how we can improve!
Take Survey
